Thiourea-Based H2S-Releasing Pramipexole Hybrids as Neuroprotective Agents
Antioxidants · 15.05.2026 · 15 (5) · 628
DOI: 10.3390/antiox15050628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 15.05.2026. Verfasst von Angela Corvino und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Naples, Italy. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multitarget hybrid molecules are a promising strategy for treating complex neurodegenerative disorders such as Parkinson’s disease (PD), where dopaminergic dysfunction, oxidative stress, neuroinflammation, and cellular senescence coexist and drive disease progression. Here, we developed pramipexole-derived hydrogen sulfide (H2S)-releasing hybrids using, for the first time, a thiourea moiety as an H2S-donating linker to extend the therapeutic profile of pramipexole beyond dopamine receptor agonism. The hybrids were synthesized and characterized, and their H2S-releasing properties were assessed by amperometric and intracellular detection assays. Among the series, compound 2e (PRAM-ADA) showed the most efficient and sustained H2S release, indicating a favorable thiol-dependent release profile. PRAM-ADA was further evaluated for antioxidant and anti-senescent activities in BV2 microglial cells, as well as for chemical and enzymatic stability under simulated physiological conditions. The hybrid significantly reduced LPS-induced reactive oxygen species accumulation and attenuated oxidative stress–induced cellular senescence, demonstrating a superior cytoprotective profile compared with pramipexole. These findings support the concept that combining dopaminergic activity with controlled H2S donation enhances antioxidant and anti-senescent responses, indicating their potential as multitarget agents with neuroprotective properties relevant to neurodegenerative disorders, including PD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Naples, Italy.
- Department of Pharmacy, University of Pisa, Via Bonanno 6, 56125 Pisa, Italy.
- Department for Life Quality Studies, Alma Mater Studiorum-Università di Bologna, Corso d'Augusto 237, 47921 Rimini, Italy.
- Department of Public Health, School of Medicine, University of Naples Federico II, Via Panzini, 5, 80131 Naples, Italy.
ORCID-Profile: Angela Corvino, Antonia Scognamiglio, Alma Martelli, Giulia Neggiani, Carmela Fimognari, Ferdinando Fiorino, Elisa Magli, Rosa Sparaco, Beatrice Severino
Zitieren
APA
Corvino, A., Citi, V., Scognamiglio, A., Martelli, A., Calderone, V., Neggiani, G., Fimognari, C., Fiorino, F., Magli, E., Sparaco, R., Santagada, V., Caliendo, G., & Severino, B. (2026). Thiourea-Based H2S-Releasing Pramipexole Hybrids as Neuroprotective Agents. Antioxidants, 15(5), 628. https://doi.org/10.3390/antiox15050628
Vancouver
Corvino A, Citi V, Scognamiglio A, Martelli A, Calderone V, Neggiani G, et al. Thiourea-Based H2S-Releasing Pramipexole Hybrids as Neuroprotective Agents. Antioxidants. 2026;15(5):628. doi:10.3390/antiox15050628
BibTeX
@article{Corvino2026,
author = {Corvino, Angela and Citi, Valentina and Scognamiglio, Antonia and Martelli, Alma and Calderone, Vincenzo and Neggiani, Giulia and Fimognari, Carmela and Fiorino, Ferdinando and Magli, Elisa and Sparaco, Rosa and Santagada, Vincenzo and Caliendo, Giuseppe and Severino, Beatrice},
title = {Thiourea-Based H2S-Releasing Pramipexole Hybrids as Neuroprotective Agents},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {5},
pages = {628},
doi = {10.3390/antiox15050628}
}
EUVIMED